Skip to main content

Normal Saline for Parenteral Use Market Size to Surpass USD 5.48 Billion by 2030, exhibiting a CAGR of 6.9%

As per the report by Fortune Business Insights, the global normal saline for parenteral use market size is projected to reach USD 5.48 billion in 2030, at a CAGR of 6.9% during the forecast period, 2023-2030

Normal Saline for Parenteral Use Market

Normal Saline for Parenteral Use Market Forecast (2023-2030)
Normal Saline for Parenteral Use Market Forecast (2023-2030)

Pune, India, Oct. 18, 2023 (GLOBE NEWSWIRE) — The normal saline for parenteral use market size expected to expand from USD 3.44 billion in 2023 to USD 5.48 billion by 2030, exhibiting a CAGR of 6.9% over the study period. Expansion can be credited to growing government recommendations and regulations for deployment of 0.9% sodium chloride and fluid resuscitation in severe conditions.

Fortune Business Insights™ provides this information in its research report titled “Normal Saline for Parenteral Use Market, 2023-2030”.

Key Industry Development:

August 2020 – ICU Medical, Inc. inked a long-term deal with Grifols for the distribution of non-PVC/non-DEHP IV containers for 0.9% NaCl Injection, USP to the U.S. people.


Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/normal-saline-for-parenteral-use-market-104520


Key Takeaways:

  • The flu season has led to a rise in the need for intravenous saline products, essential for hydrating and administering medications to hospitalized patients.
  • Increasing uptake of saline across various medical specialties in hospitals and clinics is a major factor bolstering the market growth.
  • The segment is expected to grow at a considerable CAGR during 2023-2030
  • The North American market stood at USD 1.26 billion in 2022.


List of Key Players Mentioned in the Report:

“Companies leading the normal saline for parenteral use market are Baxter (U.S.), Kelun Group (China), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), SSY Group Limited (China), ICU Medical (U.S.), Double-Crane Pharmaceutical Co., Ltd. (China), Otsuka Pharmaceutical Co., Ltd. (Japan), Cisen Pharmaceutical Co., Ltd. (China), Pharmally International Holding Co., Ltd. (China)”


Report Scope:

Report CoverageDetails
Forecast Period2023 to 2030
Forecast Period 2023 to 2030 CAGR6.9%
2030 Value ProjectionUSD 5.48 Billion
Base Year2022
Market Size in 2022USD 3.24 Billion
Historical Data2019 to 2021
No. of Pages118
Segments coveredBy Type, By Application, and Region


Browse Complete Report Details: https://www.fortunebusinessinsights.com/normal-saline-for-parenteral-use-market-104520


Segmentation:

Increasing Preference for Plastic Bottles to Proliferate the Segment Expansion

On the basis of type, the market is bifurcated into glass bottles and plastic bottles. The plastic bottles segment is expected to account for the largest normal saline for parenteral use market share during the forecast period. The plastic bottles are increasingly preferred over glass bottles for the prevention of breakage during distribution. This factor is impelling the segment expansion.

Increasing Prevalence of Diarrhea to Fuel the Intravenous Segment Growth

With respect to application, the market is divided into intravenous injection and intramuscular injection. The intravenous segment held the largest market share in 2022. The surging occurrence of diarrhea, food poisoning, and vomiting is accelerating the segment growth.
From the regional perspective, the market is divided into the Asia Pacific, North America, the Middle East & Africa, Europe, and Latin America.


By Type

  • Plastic Bottles
  • Glass Bottles

By Application

  • Intramuscular injection
  • Intravenous injection

 By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


Quick Buy – Normal Saline for Parenteral Use Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104520


Drivers and Restraints:

Growing Number of Surgeries and Hospitalizations to Escalate the Market Growth

One of the major factors impelling the normal saline for parenteral use market growth is the growth in the number of hospital admissions and surgical procedures. Due to the growing number of hospitalizations in NICUs and ICUs, the demand for the solution has increased.

The increasing number of hospital admissions in ICUs and NICUs has resulted in an increased demand for normal saline for parenteral use.

Despite such growth opportunities, research stating the substitution of saline with balanced fluids may impede the market growth.

Regional Insights:

North America Dominated Due to the Growing Adoption of 0.9% NaCl

North America market for normal saline for parenteral use accounted for the largest share in 2022. The surging deployment of 0.9% NaCl is bolstering the regional growth.

The Asia Pacific market is poised to register the second leading position during the forecast period on account of the rising geriatric population.


Competitive Landscape:

Notable Companies Focus on Partnerships to Strengthen Their Market Position

The leading normal saline for parenteral use market players are deploying different strategic initiatives such as product innovations, mergers and acquisitions, joint ventures, and others. Notable companies are also focusing on entering partnerships to maximize their revenue.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/normal-saline-for-parenteral-use-market-104520


FAQs

How big is the normal saline for parenteral use market?

Normal saline for parenteral use market size is USD 3.44 billion in 2023 and it is expected to reach USD 5.48 billion in 2030.

How fast is the normal saline for parenteral use market growing?

The normal saline for parenteral use market will exhibit a CAGR of 6.9% during the forecast period, 2023-2030.


Related Reports:

Injectable Drug Delivery Market Size, Share, Revenue Forecast and Opportunities

Incontinence Products Market Overview, Industry Share and Forecast


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India.

Phone:

U.S.:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.